TheraPanacea
Rémi Vauclin has a diverse work experience spanning multiple roles and industries.
Their most recent position is as a Senior Optimization Engineer at TheraPanacea, where they started in April 2021 and is presently employed.
Prior to this, Rémi worked as a Research and Development Engineer at Color Grail Research for six years, from February 2015 to April 2021.
In 2014, Rémi served as a Visiting Research Scholar at the University of Florida, from October 2014 to January 2015.
Before that, Rémi was a Graduation Intern at ISAE-SUPAERO from March 2014 to September 2014.
Rémi began their professional career as an Engineering Intern at EDF in May 2013 until September 2013.
Rémi Vauclin pursued their education in a systematic manner, starting with their Bachelor's degree in Mathematics and Physics at Lycée Condorcet from 2009 to 2011. Rémi then advanced their studies and obtained a Master's degree in Applied Mathematics from École des Mines de Saint-Étienne, completing the program from 2011 to 2014.
This person is not in any offices
TheraPanacea
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Today, ART-Plan™, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year. TheraPanacea also develops and operates the ART-Omics™ platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.